Abstract
Second-generation (G2) polyamidoamine (PAMAM) dendrimers are branched polymers containing 16 surface primary amine groups. Due to their structural properties, these polymers can be used as universal carriers in various drug delivery systems. Amine-terminated PAMAM dendrimers are characterized by a high positive surface charge, leading to effective but nonspecific interactions with negatively charged cell plasmatic membranes. To reduce the nonspecific internalization of PAMAM dendrimers, their primary amine groups are often modified by acetic or succinic anhydrides, polyethylene glycol derivatives and other compounds. In this work, the role of primary amine groups, which are localized on the surface of doxorubicin-conjugated (Dox) dendrimers, was studied with regard to their intracellular distribution and internalization rates using SKOV3 human ovarian adenocarcinoma cells. It was demonstrated that all Dox-labeled G2-derivatives containing different numbers of acetamide groups synthesized in this work show high rates of cellular uptake at 37°С. As expected, the conjugate carrying the maximum number of primary amine groups demonstrated the highest rates of binding and endocytosis. At the same time, the G2-Dox conjugate containing the maximum number of acetamide groups showed colocalization with LAMP2, a marker of lysosomes and late endosomes, as well as the highest level of cytotoxic activity against SKOV3 cells. We conclude that second-generation PAMAM dendrimers are characterized by varied pathways of internalization and intracellular distribution due to the number of primary amine groups on their surface and, as a consequence, a different surface charge.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Abbreviations
- PAMAM:
-
polyamidoamine dendrimers
- G2:
-
second-generation polyamidoamine dendrimers
- Dox:
-
doxorubicin
- SKOV3:
-
human ovarian adenocarcinoma cells
- G2-Dox:
-
doxorubicin-conjugated second-generation polyamidoamine dendrimers
- LAMP2:
-
lysosomal and late endosomal marker
References
Svenson, S. and Tomalia, D.A., Adv. Drug Delivery Rev., 2005, vol. 57, no. 15, pp. 2106–2129.
Tomalia, D.A., Prog. Polym. Sci., 2005, vol. 30, nos. 3–4, pp. 294–324.
Gupta, U., Agashe, H.B., Asthana, A., and Jain, N.K., Biomacromolecules, 2006, vol. 7, no. 3, pp. 649–658.
Cheng, Y.Y., Xu, Z.H., Ma, M.L., and Xu, T., J. Pharm. Sci., 2008, vol. 97, no. 1, pp. 123–143.
Emanuele, A. and Attwood, D., Adv. Drug Delivery Rev., 2005, vol. 57, no. 15, pp. 2147–2162.
Gillies, E.R. and Frechet, J.M.J., Drug Discovery Today, 2005, vol. 10, no. 1, pp. 35–43.
Srinivasa-Gopalan, S. and Yarema, K.J., Nanotechnol. Life Sci., 2007, vol. 7, pp. 1–43.
Haba, Y., Harada, A., Takagishi, T., and Kono, K., Polymer, 2005, vol. 46, no. 6, pp. 1813–1820.
Orive, G., Hernandez, R.M., Gascon, A.R., and Pedraz, J.L., Cancer Therapy, 2005, vol. 3, pp. 131–138.
Patri, A.K., Majoros, I.J., and Baker, J.J.R., Curr. Opin. Chem. Biol., 2002, vol. 6, no. 4, pp. 466–471.
Cheng, Y., Wang, J., Rao, T., et al., Front. Biosci., 2008, vol. 1, no. 13, pp. 1447–1471.
Wyszogrodzka, M. and Haag, R., Chemistry, 2008, vol. 14, no. 30, pp. 9202–9214.
Kojima, S., Expert Opin. Drug Metab. Toxicol., 2015, vol. 11, no. 8, pp. 1303–1315.
Cai, X., Hu, J., Xiao, J., and Cheng, Y., Expert Opin. Drug Metab. Toxicol., 2013, vol. 23, no. 4, pp. 515–529.
Perumal, O.P., Inapagolla, R., Kannan, S., and Kannan, R.M., Biomaterials, 2008, vol. 29, pp. 3469–3476.
Kitchens, K.M., Kolhatkar, R.B., Swaan, P.W., and Ghandehari, H., Mol. Pharm., 2008, vol. 5, pp. 364–369.
Saovapakhiran, A., D’Emanuele, A., Attwood, D., and Penny, J., Bioconjug. Chem., 2009, vol. 20, pp. 693–701.
Qi, R., Mullen, D.G., Baker, J.R., and Banaszak Holl, M.M., Mol. Pharm., 2009, vol. 7, pp. 267–279.
Kitchens, K.M., Foraker, A.B., Kolhatkar, R.B., Swaan, P.W., and Ghandehari, H., Pharm. Res., 2007, vol. 24, pp. 2138–2145.
Anno, T., Higashi, T., Hayashi, Y., Motoyama, K., Jono, H., Ando, Y., and Arima, H., J. Drug. Target, 2014, vol. 22, no. 10, pp. 883–890.
Yabbarov, N.G., Posypanova, G.A., Vorontsov, E.A., Popova, O.N., and Severin, E.S., Biochemistry (Moscow), 2013, vol. 78, no. 8, pp. 884–894.
Shen, W.C. and Ryser, H.J., Biochem. Biophys. Res. Commun., 1981, vol. 102, pp. 1048–1054.
Denizot, F. and Lang, R., J. Immunol. Methods, 1986, vol. 89, pp. 271–277.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N.G. Yabbarov, E.D. Nikolskaya, O.A. Zhunina, I.G. Kondrasheva, I.A. Zamulaeva, E.S. Severin, 2017, published in Bioorganicheskaya Khimiya, 2017, Vol. 43, No. 2, pp. 180–188.
Rights and permissions
About this article
Cite this article
Yabbarov, N.G., Nikolskaya, E.D., Zhunina, O.A. et al. Polyamidoamine dendrimers with different surface charge as carriers in anticancer drug delivery. Russ J Bioorg Chem 43, 155–162 (2017). https://doi.org/10.1134/S1068162017020182
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1068162017020182